Sign inJoin waitlistJoin the waitlist

Barbara Norquist

Associate Chair of Research · University of Washington School of Medicine

Credentials: · · · ·

History

Research · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Gynecologic Oncology
University of Washington School of Medicine
2009–2012
Obstetrics and Gynecology
University of Washington School of Medicine
2004–2005
University of Washington School of Medicine
2000–2004

Research

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 914 citations
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas
Clinical Cancer Research · 2014 · 840 citations
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Proceedings of the National Academy of Sciences of the United States of America · 2011 · 741 citations

Elizabeth Swisher
52 papers
Rochelle Garcia
21 papers
KP
Kathryn Pennington
20 papers · 3 as a fellow
Karen Lu
11 papers
MK
Mark Kilgore
9 papers
Talayeh Ghezelayagh
8 papers · 7 as a fellow
DL
Douglas Levine
7 papers
Allison Kurian
6 papers
Denise Nebgen
6 papers · 1 as a resident
Stephanie Blank
6 papers
Beth Karlan
5 papers
Brian Shirts
5 papers

Clinical trials

Uterine Lavage to Detect Ovarian Cancer Risk
Principal investigator · Recruiting
University of Washington
2026–2028
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
Principal investigator · Terminated
University of Washington
2018–2022
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Site PI · Recruiting
M.D. Anderson Cancer Center
2022–2026
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Site PI · Recruiting
NRG Oncology
2020–2047